Activist Saba Capital Amends Board Nominee Slate, Reports $2.56M in Share Sales
ECAT is trading near its 52-week low of $13.35 (13% above the low).
Summary
Activist investor Saba Capital Management updated its board nominations for BlackRock ESG Capital Allocation Term Trust and reported recent share sales totaling $2.56 million.
Key Events · Ownership and Investor Activity · ECAT
-
Updated Board Nominee Slate
Saba Capital Management withdrew one Class III nominee (Kim Schawbel) and nominated three new individuals: Lawrence Epstein (Class I), Wayne Threatt (Class III), and Lihong Wang (Class III) for the company's board.
-
Reported Share Sales
Saba Capital sold 169,301 shares for a total of approximately $2.56 million between February 19 and February 25, 2026.
-
Continuation of Activist Campaign
This filing marks a continuation and modification of Saba Capital's activist efforts, following its previous nomination of a full slate of trustees on February 19, 2026, and earlier share reductions.
Analysis · ECAT · Unknown
Activist investor Saba Capital Management, holding a 23.73% stake, has filed an amendment to its Schedule 13D, updating its slate of nominees for the company's board. This filing withdraws one previously proposed nominee and introduces three new Class I and Class III nominees. This action continues Saba Capital's ongoing activist campaign, which previously included the nomination of a full slate of trustees on February 19, 2026. Additionally, the filing reports that Saba Capital sold approximately $2.56 million worth of shares between February 19 and February 25, 2026. This indicates a continued push for board representation while also adjusting its position.
At the time of this filing, ECAT was trading at $15.14 on NYSE in the Unknown sector. The 52-week trading range was $13.35 to $17.14. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.